A Phase 1 Study to Evaluate the Safety and Immunogenicity of eOD-GT8 60mer mRNA Vaccine (mRNA-1644) and Core-g28v2 60mer mRNA Vaccine (mRNA-1644v2-Core)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05001373 |
|
Recruitment Status :
Active, not recruiting
First Posted : August 11, 2021
Last Update Posted : May 1, 2024
|
Sponsor:
International AIDS Vaccine Initiative
Collaborators:
ModernaTX, Inc.
George Washington University
Fred Hutchinson Cancer Center
Emory University
UT Health San Antonio
Information provided by (Responsible Party):
International AIDS Vaccine Initiative
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Active, not recruiting |
|---|---|
| Actual Primary Completion Date : | June 20, 2023 |
| Estimated Study Completion Date : | July 1, 2024 |